These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 31864114)

  • 1. Effect of drug molecular weight on niosomes size and encapsulation efficiency.
    García-Manrique P; Machado ND; Fernández MA; Blanco-López MC; Matos M; Gutiérrez G
    Colloids Surf B Biointerfaces; 2020 Feb; 186():110711. PubMed ID: 31864114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methods for preparation of niosomes: A focus on thin-film hydration method.
    Thabet Y; Elsabahy M; Eissa NG
    Methods; 2022 Mar; 199():9-15. PubMed ID: 34000392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dermal targeting of
    Wichayapreechar P; Anuchapreeda S; Phongpradist R; Rungseevijitprapa W; Ampasavate C
    J Liposome Res; 2020 Jun; 30(2):197-207. PubMed ID: 31060402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An electron spin resonance study of non-ionic surfactant vesicles (niosomes).
    Yeom S; Shin BS; Han S
    Chem Phys Lipids; 2014 Jul; 181():83-9. PubMed ID: 24721595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of niosomes prepared with various nonionic surfactants for paclitaxel oral delivery.
    Bayindir ZS; Yuksel N
    J Pharm Sci; 2010 Apr; 99(4):2049-60. PubMed ID: 19780133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of novel diolein-niosomes for cutaneous delivery of tretinoin: influence of formulation and in vitro assessment.
    Manca ML; Manconi M; Nacher A; Carbone C; Valenti D; Maccioni AM; Sinico C; Fadda AM
    Int J Pharm; 2014 Dec; 477(1-2):176-86. PubMed ID: 25455770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physicochemical properties and skin permeation of Span 60/Tween 60 niosomes of ellagic acid.
    Junyaprasert VB; Singhsa P; Suksiriworapong J; Chantasart D
    Int J Pharm; 2012 Feb; 423(2):303-11. PubMed ID: 22155414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro characterisation of Span 65 niosomal formulations containing proteins.
    Haj-Ahmad RR; Elkordy AA; Chaw CS
    Curr Drug Deliv; 2015; 12(5):628-39. PubMed ID: 25963305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Niosomes as carriers of radiopaque contrast agents for X-ray imaging.
    Muller D; Foulon M; Bonnemain B; Vandamme TF
    J Microencapsul; 2000; 17(2):227-43. PubMed ID: 10738698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of formulation compositions on niosomal preparations.
    Chaw CS; Kim KY
    Pharm Dev Technol; 2013; 18(3):667-72. PubMed ID: 22468904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and optimization of topical methotrexate loaded niosomes for enhanced management of psoriasis: application of Box-Behnken design, in-vitro evaluation and in-vivo skin deposition study.
    Abdelbary AA; AbouGhaly MH
    Int J Pharm; 2015 May; 485(1-2):235-43. PubMed ID: 25773359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation of niosomes as an ocular delivery system for naltrexone hydrochloride: physicochemical characterization.
    Abdelkader H; Ismail S; Kamal A; Alany RG
    Pharmazie; 2010 Nov; 65(11):811-7. PubMed ID: 21155387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and in vitro evaluation of doxycycline hyclate niosomes as a potential ocular delivery system.
    Gugleva V; Titeva S; Rangelov S; Momekova D
    Int J Pharm; 2019 Aug; 567():118431. PubMed ID: 31207279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in non-ionic surfactant vesicles (niosomes): Fabrication, characterization, pharmaceutical and cosmetic applications.
    Chen S; Hanning S; Falconer J; Locke M; Wen J
    Eur J Pharm Biopharm; 2019 Nov; 144():18-39. PubMed ID: 31446046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single Intravenous Dose of Novel Flurbiprofen-Loaded Proniosome Formulations Provides Prolonged Systemic Exposure and Anti-inflammatory Effect.
    Verma P; Prajapati SK; Yadav R; Senyschyn D; Shea PR; Trevaskis NL
    Mol Pharm; 2016 Nov; 13(11):3688-3699. PubMed ID: 27632682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effects of Hydration Parameters and Co-Surfactants on Methylene Blue-Loaded Niosomes Prepared by the Thin Film Hydration Method.
    Yeo LK; Chaw CS; Elkordy AA
    Pharmaceuticals (Basel); 2019 Mar; 12(2):. PubMed ID: 30934834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of different types of surfactants on the physical properties and stability of carvedilol nano-niosomes.
    Taymouri S; Varshosaz J
    Adv Biomed Res; 2016; 5():48. PubMed ID: 27110545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes.
    Mokhtar M; Sammour OA; Hammad MA; Megrab NA
    Int J Pharm; 2008 Sep; 361(1-2):104-11. PubMed ID: 18577437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanovesicles as Vanillin Carriers for Antimicrobial Applications.
    Marchianò V; Matos M; López M; Weng S; Serrano-Pertierra E; Luque S; Blanco-López MC; Gutiérrez G
    Membranes (Basel); 2023 Jan; 13(1):. PubMed ID: 36676902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sorbitane Monostearate and Cholesterol based Niosomes for Oral Delivery of Telmisartan.
    Ahad A; Raish M; Al-Jenoobi FI; Al-Mohizea AM
    Curr Drug Deliv; 2018 Feb; 15(2):260-266. PubMed ID: 28521674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.